DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,162,250 | +1.3% | 73,205 | -2.0% | 0.84% | +3.2% |
| Q2 2023 | $17,930,967 | -7.2% | 74,712 | -2.6% | 0.81% | -12.0% |
| Q1 2023 | $19,329,200 | +92677.2% | 76,691 | -2.3% | 0.92% | -1.1% |
| Q4 2022 | $20,834 | -99.9% | 78,496 | -5.0% | 0.93% | -7.9% |
| Q3 2022 | $21,351,000 | -5.2% | 82,663 | -6.9% | 1.01% | +2.6% |
| Q2 2022 | $22,520,000 | -43.3% | 88,828 | -34.4% | 0.99% | -29.2% |
| Q1 2022 | $39,748,000 | -9.0% | 135,506 | +2.0% | 1.39% | -1.2% |
| Q4 2021 | $43,702,000 | -44.9% | 132,831 | -49.0% | 1.41% | -11.9% |
| Q3 2021 | $79,249,000 | +126.0% | 260,311 | +99.2% | 1.60% | +21.3% |
| Q2 2021 | $35,061,000 | +20.8% | 130,648 | +1.3% | 1.32% | +11.3% |
| Q1 2021 | $29,028,000 | +4.1% | 128,965 | +2.7% | 1.18% | -10.4% |
| Q4 2020 | $27,883,000 | +0.4% | 125,519 | -2.6% | 1.32% | -7.7% |
| Q3 2020 | $27,763,000 | +5.4% | 128,935 | +0.9% | 1.43% | +3.6% |
| Q2 2020 | $26,344,000 | +51.5% | 127,842 | +1.7% | 1.38% | +15.8% |
| Q1 2020 | $17,391,000 | -8.4% | 125,647 | +1.6% | 1.19% | +19.0% |
| Q4 2019 | $18,977,000 | +7.4% | 123,640 | +1.0% | 1.00% | -2.1% |
| Q3 2019 | $17,673,000 | -22.3% | 122,359 | -23.1% | 1.02% | -22.3% |
| Q2 2019 | $22,737,000 | +7.8% | 159,088 | -0.4% | 1.32% | +4.6% |
| Q1 2019 | $21,085,000 | +29.7% | 159,709 | +1.3% | 1.26% | +12.7% |
| Q4 2018 | $16,256,000 | -4.8% | 157,638 | +0.3% | 1.12% | +13.6% |
| Q3 2018 | $17,082,000 | +11.4% | 157,201 | +1.2% | 0.98% | +3.5% |
| Q2 2018 | $15,335,000 | +1.3% | 155,400 | +0.5% | 0.95% | -1.4% |
| Q1 2018 | $15,133,000 | +6.3% | 154,563 | +0.8% | 0.97% | +7.5% |
| Q4 2017 | $14,239,000 | +12.2% | 153,396 | +3.7% | 0.90% | +5.5% |
| Q3 2017 | $12,694,000 | +0.8% | 147,983 | -0.8% | 0.85% | -2.1% |
| Q2 2017 | $12,596,000 | -1.7% | 149,251 | -0.3% | 0.87% | +2.4% |
| Q1 2017 | $12,810,000 | +11.8% | 149,768 | +1.7% | 0.85% | +5.3% |
| Q4 2016 | $11,462,000 | +1.9% | 147,251 | +2.6% | 0.81% | -1.9% |
| Q3 2016 | $11,246,000 | -20.4% | 143,458 | +2.5% | 0.82% | -23.9% |
| Q2 2016 | $14,132,000 | +8.2% | 139,916 | +1.6% | 1.08% | +0.9% |
| Q1 2016 | $13,065,000 | +6.6% | 137,732 | +4.3% | 1.07% | +6.8% |
| Q4 2015 | $12,260,000 | +1682.0% | 131,998 | +1536.1% | 1.00% | +1573.3% |
| Q3 2015 | $688,000 | +21.8% | 8,068 | +22.3% | 0.06% | +27.7% |
| Q2 2015 | $565,000 | +2.4% | 6,598 | +1.5% | 0.05% | +2.2% |
| Q1 2015 | $552,000 | -1.8% | 6,498 | -0.9% | 0.05% | -6.1% |
| Q4 2014 | $562,000 | +20.1% | 6,560 | +6.2% | 0.05% | +16.7% |
| Q3 2014 | $468,000 | +7.3% | 6,175 | +11.3% | 0.04% | +10.5% |
| Q2 2014 | $436,000 | -4.8% | 5,550 | -9.0% | 0.04% | -9.5% |
| Q1 2014 | $458,000 | +1.6% | 6,100 | +4.4% | 0.04% | 0.0% |
| Q4 2013 | $451,000 | +11.4% | 5,841 | 0.0% | 0.04% | +5.0% |
| Q3 2013 | $405,000 | +35.9% | 5,841 | +23.7% | 0.04% | +29.0% |
| Q2 2013 | $298,000 | – | 4,721 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |